
DAYS
SPEAKERS
TALKS
SPONSORS
Conference Objectives
- Update about neurogenetic disorders clinical approach, diagnosis & management
- Update about leukodystrophies
- Update about genetic causes and treatment of epileptic encehalopathies
- Over view and update about neurotransmitters disorders
- Update about treatment of metabolic epilepsies
- Clinical approach and treatment to pediatric movement disorders
Meet the speakers

Laura A Adang, (MD, PhD)

Prof. Majid Alfadhel (MD, MHSc, SSC-Ped, ABHS(CH), FCCMG)

Dr. Fuad Al Mutairi

Dr. Amna Abdulkarim Kashgari (MD)

Prof. Fahad A. Bashiri (MBBS, ABP, SCCP, KSUBP, KFSH PNF, UBC Epilepsy Fellowship)

Dr. Makki Almuntashri (MD, FRCPC, DABR)

Dr. Muhammad Talal Alrifai (MD)

Prof. Mohammad A Al-Muhaizea (MD, MBA (IHM))
Conference Agenda
Day 1, Friday 2nd July, 2021
Leukodystrophies

Diagnostic Algorithm for Leukodystrophies

The diagnosis and management of Aicardi Goutieres Syndrome

The Leukodystrophy Spectrum in Saudi Arabia: Epidemiological, Clinical, Radiological and Genetic Data

Artificial intelligence utility in diagnosing Leukodystrophies
Day 2, Saturday 3rd July, 2021
Approach to pediatric neurometabolic/genetic disease

Approach to neuro-metabolic disorders: pediatric neurology point of view

Neuroimaging in neurogenetics disorders

Neurogenetics approach to ataxia

Neurogenetics approach to hypotonia

Therapeutic implications of genetic testing in movement disorders: real life experience
Utility of NGS in diagnosis of neurogenetic disorders

Novel neurogenetic disorders in Saudi Arabia-An update

What is the right sequencing approach? Solo VS extended family analysis in consanguineous population

Mitochondrial disorders in Saudi Arabia
Epileptic encephalopathies and neurotransmitters disorders

Treatable metabolic epilepsies

Genetic epileptic encephalopathies: treatment update

Pyridoxine dependent epilepsy in Saudi Arabia

Neurotransmitter’s disorder: over view and update